Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$509,660.00
Apr 1, 2013
Targeted nanomedicines for gene therapy applications.
$374,183.00
Apr 1, 2018
Selective laser-mediated gene therapy for ocular diseases
$906,526.00
Oct 1, 2018
Gene Therapy to Prevent Blindness in Patients with Congenital Aniridia
$150,000.00
May 1, 2017
Therapy development for pediatric diseases by gene correction in vivo
$513,029.00
Apr 1, 2012
Designing Amphiphilic Polymeric Carriers of DNA for Gene Therapy
$318,420.00
Apr 1, 2014
A gene therapy strategy for recessive distrophic epidermolysis bullosa
$100,000.00
Oct 1, 2014
Gene Therapy for PAX6-Aniridia: Focusing on the Eye
$105,000.00
May 1, 2016
A Novel Approach to Gene Therapy for the Treatment of Spinal Muscular Atrophy
$955,625.00
Jul 1, 2016
Development of small RNAs for HIV-1 gene and drug therapy
$978,560.00
Jul 1, 2016
Non-invasive gene therapy for Parkinson's disease and other synucleinopathies